Annovis Bio to Participate in the 139th Yale CEO Summit

December 12, 2023

https://www.globenewswire.com/news-release/2023/12/11/2794161/0/en/Annovis-Bio-to-Participate-in-the-139th-Yale-CEO-Summit.html

BERWYN, Pa., Dec. 11, 2023 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE:ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases such as Alzheimer’s (AD) and Parkinson’s disease (PD) today announced its Founder, President and CEO was selected to participate in the 139th Yale CEO Summit in New York on December 11-12, 2023. 

Read more at globenewswire.com

Related news for (ANVS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.